Hrt Financial LP Windtree Therapeutics Inc Transaction History

Hrt Financial LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$0.16 - $281.7 $5,279 - $9.3 Million	32,999 New	32,999 $5,000
Q2 2021 Aug 16, 2021	SELL	$1.68 - $2.79 $39,253 - $65,188	-23,365 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$2.14 - $6.18 $50,001 - $144,395	23,365 New	23,365 $57,000

4.09K

Ticker WINT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,627,900
Market Cap $9.49M
Description
Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include istaroxime, which is in Phase IIb clinical trial for the treatment of acute decompensated heart ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.